Back

A cohort study examining predictors of stroke and bleeding among people with congenital heart disease and atrial fibrillation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Optimising care in adult congenital heart disease Adult Congenital Heart Disease (ACHD) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Michael Patrick O'Shea

Mayo Clinic Hospital, Phoenix (United States of America)

8 More presentations in this session

Presentation thumbnail
Optimising liver screening in patients with a Fontan circulation: a cost-effective approach to detection of Fontan associated liver disease which enhances patient care
Mr H. Mathew (London, GB)
Abstract Slides Video
Presentation thumbnail
Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis
Doctor L. Tsigkriki (Chania, GR)
Abstract Slides Video
Presentation thumbnail
Reverse cardiac remodeling induced by endovascular treatment of coarctation of the aorta
Assistant Professor M. Farrashi (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronization therapy in adult congenital heart disease: single center cohort study
Doctor O. Rahat (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Antithrombotic treatment in univentricular heart
Doctor A. Ozturk (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising care in adult congenital heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: a prospective cohort study with historical control comparison
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study
thumbnail
Congress Presentation
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources